UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000016213
Receipt No. R000018742
Scientific Title A feasibility study of dose-dense epirubicin and cyclophosphamide for primary breast cancer in neoadjuvant and adjuvant setting
Date of disclosure of the study information 2015/01/28
Last modified on 2017/12/19 09:47:40

No. Disposal Last modified on Item of update
1 Insert 2015/01/14 17:51:59
2 Update 2015/02/27 09:48:11 Public title
Public title
3 Update 2015/02/27 09:49:45 Narrative objectives1
Narrative objectives1
4 Update 2015/02/27 09:50:59 Key inclusion criteria
Key inclusion criteria
5 Update 2015/03/11 11:07:06 Recruitment status
Anticipated trial start date
6 Update 2015/07/31 16:19:29 Condition
Primary outcomes
Key secondary outcomes
Key secondary outcomes
7 Update 2015/07/31 16:21:43 Key secondary outcomes
Key secondary outcomes
8 Update 2016/07/11 16:12:35 Name of primary sponsor
Organization
Category of Funding Organization
9 Update 2016/07/11 16:14:56 Recruitment status
10 Update 2017/12/19 09:47:40 Recruitment status
Publication of results
URL related to results and publications


Contact us.